Cannabinoids
In clinical developmentRecent clinical, regulatory, research and industry developments relating to this drug.
Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders.
An enquiry to the role of CB1 receptors in neurodegeneration.
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
The Effect of Dispensed Cannabis on Taxane Induced Peripheral Neuropathy
Designer drugs: mechanism of action and adverse effects.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Cannabinoid receptors: where they are and what they do.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- The Journal of neuroscience : the official journal of the Society for Neuroscience2
- Archives of toxicology1
- Basic & clinical pharmacology & toxicology1
- Cells1
- International journal of molecular sciences1
- JAMA1
- Mackie K3
- Freund TF2
- Katona I2
- Acsady L1
- Bhattacharya S1
- Bloemer J1
- Brown J1
- Chowdhury K1
- Institute of Experimental Medicine2
- Auburn University1
- Behavioural Neurosciences Institute (INeC)1
- Center for Agropastoralism Sciences and Technology (CCTA)1
- Center for Neuroscience Initiative1
- Center for Physiology and Pharmacology1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 4 of the same disease areas as Cannabinoids in the shared literature.
Studied across 3 of the same disease areas as Cannabinoids in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials